Integrated DNA Technologies (IDT)

Integrated DNA Technologies Expands Coralville Manufacturing Footprint to Support Growing Global Demand for MRD Solutions

Expanded footprint delivers speed, scale and customization minimal residual disease (MRD) innovators need without compromising quality Increased production capacity leverages IDT’s highly specialized, high-throughput manufacturing platform. 20 April 2026 -- Iowa, US -- Integrated DNA Technologies (IDT), a Danaher company and a global leader in genomics, today announced the expansion of its manufacturing footprint in...

Integrated DNA Technologies Expands Synthetic Biology Portfolio with Ansa Biotechnologies’ Clonal DNA and XL Clonal DNA Products

New collaboration empowers customers with sequence-perfect constructs as long as 50 kb 14 January 2026 -- California, US -- Integrated DNA Technologies (IDT), a Danaher company and a global leader in genomics, and Ansa Biotechnologies, Inc., a trusted partner for DNA synthesis, today announced a strategic collaboration that adds new complementary capabilities to IDT’s synthetic...

Integrated DNA Technologies acquires oligonucleotide synthesis company ValueGene, Inc.

Global leader in custom nucleic acid synthesis announces the acquisition of oligonucleotide synthesis service